Skip to main content
. 2022 Oct 25;8(2):e002386. doi: 10.1136/rmdopen-2022-002386

Table 1.

Baseline characteristics of lupus nephritis patients of African descent versus Caucasians

African descent (n=52) Caucasian (n=85) P value
Age 31.7 (±12) 29.4 (±9.0) 0.16
Women 50 (96%) 75 (88%) 0.13
Diagnosis decade
 <2000 1 (2%) 19 (22%) <0.001
 2000–2010 13 (25%) 41 (48%)
 >2010 38 (73%) 25 (29%)
Histological class <0.001
 III±V (N; %) 20 (38%) 18 (21%)
 IV±V (N; %) 19 (37%) 61 (72%)
 V only (N; %) 13 (25%) 6 (7%)
 Biology
 Anti-DNA antibodies 45 (87%) 56 (66%) 0.004
 aPL antibodies 10 (19%) 14 (16%) 0.72
Initial immunosuppressive drug <0.001
 CYC (N; %) 19 (37%) 63 (74%)
 MMF (N; %) 25 (48%) 15 (17%)
 Others (N; %) 8 (15%) 7 (8%)
 Other drugs
 Intravenous MP (N; %) 28 (54%) 63 (74%) 0.01
 HCQ (N; %) 41 (79%) 65 (77%) 0.7
Biological parameters
 Creatinine (mg/dL) 1.16 (±1.5) 1.01 (± 0.5) 0.39
 eGFR (mL/min/1.73 m²) 93.9 (±40) 95.0 (±41) 0.87
 Serum C3 (g/L) 0.64 (±0.3) 0.62 (±0.3) 0.8
 Serum C4 (g/L) 0.12 (0.1) 0.10 (0.05) 0.1
 uP/C (g/g) 3.53 (±5.2) 3.27 (±2.7) 0.7

Unless stated otherwise, values are mean±SD. P value <0.05 was considered statistically significant.

uP/C, urine protein to creatinine ratio.aPL, anti-phospholipid; CYC, cyclophosphamide; eGFR, estimated glomerular filtration rate; HCQ, hydroxychloroquine; MMF, mycophenolate mofetil; MP, methylprednisolone.